Vaxxinity Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019
Cash & Equivalents	5.04	33.48	144.89	31.14	0.48
Short-Term Investments	25.46	53.35	0.87	0.01	0
Cash & Cash Equivalents	30.5	86.83	144.89	31.14	0.48
Cash Growth	-64.87%	-40.07%	365.22%	6442.65%	-
Receivables	0.41	0.41	0.39	0.39	0.3
Inventory	0	6.12	8.51	3.31	0
Other Current Assets	2.32	0.52	-0.53	0.82	0.66
Total Current Assets	33.23	93.89	154.13	35.67	1.44
Property, Plant & Equipment	11.08	12.51	12.37	12.16	0.16
Long-Term Investments	0	0	0.17	0.06	0
Other Long-Term Assets	0.04	0	0	2.25	0
Total Long-Term Assets	11.12	12.51	12.54	14.47	0.16
Total Assets	44.35	106.4	166.67	50.14	1.6
Accounts Payable	1.78	5.3	3.19	1.02	1.28
Current Debt	1.91	1.5	0.38	27.59	13.19
Other Current Liabilities	13.92	24.14	23.93	8.61	5.41
Total Current Liabilities	17.61	30.94	27.49	37.22	19.88
Long-Term Debt	13.26	13.05	10.32	10.71	1.15
Other Long-Term Liabilities	0.08	0.24	0.24	89.58	29.08
Total Long-Term Liabilities	13.34	13.28	10.56	100.29	30.23
Total Liabilities	30.94	44.22	38.05	137.52	50.11
Total Debt	15.17	14.55	10.7	38.31	14.33
Debt Growth	4.25%	35.98%	-72.07%	167.23%	-
Common Stock	0.28	0.28	0.28	0.27	0.27
Retained Earnings	-361.64	-304.7	-229.48	-92.31	-52.35
Comprehensive Income	0.01	-0.2	0	-62.48	-26.82
Shareholders' Equity	13.41	62.18	128.62	-87.38	-48.51
Total Liabilities and Equity	44.35	106.4	166.67	50.14	1.6
Net Cash / Debt	15.33	72.28	135.06	-7.15	-13.86
Net Cash / Debt Growth	-78.79%	-46.48%	-	-	-
Net Cash Per Share	0.12	0.57	1.08	-0.06	-0.11
Working Capital	15.62	62.95	126.64	-1.55	-18.44
Book Value Per Share	0.11	0.49	1.03	-0.70	-0.39

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.